Seattle, WA, United States of America

Timothy Lee Hayes

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Adaptive Biotechnologies Corporation. Active years: 2022.

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2022

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations of Timothy Lee Hayes

Introduction

Timothy Lee Hayes is an accomplished inventor based in Seattle, WA. He has made significant contributions to the field of immunology, particularly in the development of methods for determining antigen-specific T cells.

Latest Patents

Hayes holds a patent for "Determining WT-1 specific T cells and WT-1 specific T cell receptors (TCRs)." This invention focuses on methods for identifying antigen-specific T cells and T cell receptors that bind to the Wilms' tumor antigen-1 (WT1) protein. The patent also includes polynucleotides encoding the TCRs, engineered cells that express these TCRs, and methods for their production and application. He has 1 patent to his name.

Career Highlights

Timothy Lee Hayes is associated with Adaptive Biotechnologies Corporation, where he applies his expertise in T cell research. His work has the potential to advance therapeutic strategies for various cancers and other diseases.

Collaborations

Hayes collaborates with notable colleagues, including Mark Klinger and Peter J R Ebert, contributing to a dynamic research environment.

Conclusion

Timothy Lee Hayes is a prominent figure in the field of immunology, with a focus on T cell research and innovative methodologies. His contributions are paving the way for advancements in cancer treatment and immunotherapy.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…